Ledger.Open graph →

SEC Form D · Amendment · filed November 13, 2018

Concentric Analgesics, Inc

Offering

$20.0M

Sold

$20.0M

Exemption

Rule 506(b)

Industry

Biotechnology

Location

SAN FRANCISCO, CA

Type

—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (12)

John F. Donovan · San Francisco, CAExec · Director Thomas F. King · San Francisco, CAExec · Director Frank J. Bellizzi · San Francisco, CAExec · Director Craig Husfeld · San Francisco, CAExec Michael Edleson · Franklin, TNExec Michele M. Samuels · La Jolla, CAExec · Director Alan Altman · Indian Wells, CAExec · Director Andrew Durstewitz · Cornelius, NCExec · Director Larry Chiarello · Shrewsbury, NJExec · Director Steve Turi · Shrewsbury, NJExec · Director Andrew Melnick · Shrewsbury, NJExec Simon Palmer · New York, NYExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗